Filing Flows › Materials › Scotts Miracle-Gro (SMG)
Scotts Miracle-Gro (SMG) earnings and revenue breakdown
Latest: Q3 FY26 · 10-Q filed Aug 5, 2026 · Scotts Miracle-Gro (SMG) Q3 FY26 earnings results →
Q3 FY26 Revenue up 1% year over year to $1.2B · 10¢ of every $1 of revenue kept as net profit · operating margin 14.5%
Scotts Miracle-Gro made $1.2B in Q3 FY26 (+1% Y/Y): U.S. Consumer reportable segment $1.0B, Other non-reportable operating segment $139M. Operating margin 14.5%, net earnings $112M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 5, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $1.2B in Q3 FY26, up 1% year over year and down 20% from the previous quarter. U.S. Consumer reportable segment was the largest line at 88% of revenue. Other non-reportable operating segment added $0.01B year over year (up 8%), 79% of the total change.
Gross margin was 31.2%, down 0.9 points from Q3 FY25. Operating profit was $0.17B, a 14.5% margin (down 4.7 points year over year). Operating profit fell $0.05B even though revenue rose $0.01B versus Q3 FY25, so costs grew faster than sales. Operating expenses grew 30% against revenue growth of 1%. The fastest-growing cost line was Other operating costs (+731%). Net earnings were $0.11B, down 25% year over year. The effective tax rate was 31.5%.
Operating cash flow was $0.35B (down 24% year over year), 308% of net earnings. Non-cash charges added back $0.02B of depreciation and $0.01B of share-based compensation. Working capital and other items added $0.21B. Capital expenditures of $0.02B left free cash flow of $0.32B.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 FY26 | 10-Q | Aug 5, 2026 | $1.2B | +1% | 14.5% | $112M | $346M |
| Q2 FY26 | 10-Q | May 6, 2026 | $1.5B | +5% | 27.5% | $239M | $220M |
| Q1 FY26 | 10-Q | Feb 4, 2026 | $354M | -3% | -6.2% | −$125M | −$370M |
| Q4 FY25 | 10-K | Nov 25, 2025 | $497M | — | -33.6% | −$152M | $174M |
| Q3 FY25 | 10-Q | Aug 6, 2025 | $1.2B | -4% | 19.1% | $149M | $454M |
| Q2 FY25 | 10-Q | May 7, 2025 | $1.4B | -9% | 25.2% | $218M | $188M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
Customers and suppliers named in filings
Sells to
- LOW — 52% of its revenue · Stated in 10-K (sentence) · source
- HD — 34% of its revenue · Stated in 10-K (XBRL) · source
About Scotts Miracle-Gro
The discussion below describes the business conducted by The Scotts Miracle-Gro Company, an Ohio corporation (“Scotts Miracle-Gro” and, together with its subsidiaries, the “Company,” “we,” “our” or “us”), including general developments in our business during fiscal 2025. Each reference in this Annual Report on Form 10-K (“Form 10-K”) to a “fiscal” year is to our fiscal year ended or ending, as applicable, on September 30 of the referenced year. For additional information on recent business developments, see “ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS” of this Form 10-K.
In its own words, from its 10-K, filed Nov 25, 2025.
Scotts Miracle-Gro against its Agricultural Chemicals peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +1% against the peers' median +1%. Operating margin: 14.5% against the peers' median -2.5%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| SMG Scotts Miracle-Gro | Q3 FY26 | $1.2B | +1% | 14.5% |
| MOS Mosaic | Q3 2026 | $3.1B | -10% | -3.1% |
| CF CF Industries Holdings | Q3 2026 | $1.9B | +12% | 37.7% |
| UAN CVR Partners, LP | Q3 2026 | $146M | -11% | -2.5% |
| AVD American Vanguard | Q2 2026 | $117M | -10% | -0.3% |
| CBUS Cibus | Q2 2026 | $994K | +6% | n/m |
| SNES SenesTech | Q2 2026 | $770K | +23% | -241.8% |
Source: Scotts Miracle-Gro 10-Q on SEC EDGAR · CIK 825542 · Agricultural Chemicals
13F: who owns SMG and who is buying
More on SMG
- How Scotts Miracle-Gro makes money: revenue by segment
- Scotts Miracle-Gro next earnings date and what analysts expect
- Scotts Miracle-Gro stock forecast, price target and fair value
- Who owns Scotts Miracle-Gro stock: holders, funds and Congress trades
- Scotts Miracle-Gro guidance and outlook
- Is Scotts Miracle-Gro a takeover target? LBO and rumors
- Scotts Miracle-Gro recalls, complaints and regulation
History
Every quarter: Q3 FY26 results · Q2 FY26 results · Q1 FY26 results · Q4 FY25 results · Q3 FY25 results · Q2 FY25 results
- Scotts Miracle-Gro guidance history: guided vs reported
- Scotts Miracle-Gro gross margin by quarter
- Scotts Miracle-Gro operating margin by quarter
- Scotts Miracle-Gro net income by quarter
- Scotts Miracle-Gro free cash flow by quarter
- Scotts Miracle-Gro capital expenditures by quarter
- Scotts Miracle-Gro U.S. Consumer reportable segment revenue by quarter
- Scotts Miracle-Gro Other non-reportable operating segment revenue by quarter